Your browser doesn't support javascript.
loading
Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease.
Aschenbrenner, Andrew J; Petros, Jennifer; McDade, Eric; Wang, Guoqiao; Balota, David A; Benzinger, Tammie Ls; Cruchaga, Carlos; Goate, Alison; Xiong, Chengjie; Perrin, Richard; Fagan, Anne M; Graff-Radford, Neill; Ghetti, Bernardino; Levin, Johannes; Weidinger, Endy; Schofield, Peter; Gräber, Susanne; Lee, Jae-Hong; Chhatwal, Jasmeer P; Morris, John C; Bateman, Randall; Hassenstab, Jason.
Afiliação
  • Aschenbrenner AJ; Charles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
  • Petros J; Charles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
  • McDade E; Charles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
  • Wang G; Division of Biostatistics Washington University School of Medicine St. Louis Missouri USA.
  • Balota DA; Department of Psychological and Brain Sciences Washington University in St. Louis St. Louis Missouri USA.
  • Benzinger TL; Charles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
  • Cruchaga C; Department of Radiology Washington University School of Medicine St. Louis Missouri USA.
  • Goate A; Charles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
  • Xiong C; Department of Psychiatry Washington University School of Medicine St. Louis Missouri USA.
  • Perrin R; Department of Neuroscience Icahn School of Medicine at Mount Sinai New York New York USA.
  • Fagan AM; Charles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
  • Graff-Radford N; Division of Biostatistics Washington University School of Medicine St. Louis Missouri USA.
  • Ghetti B; Division of Neuropathology Department of Pathology & Immunology Washington University School of Medicine St. Louis Missouri USA.
  • Levin J; Charles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
  • Weidinger E; Department of Neurology Mayo Clinic Jacksonville Florida USA.
  • Schofield P; Department of Pathology and Laboratory Medicine Indiana University School of Medicine Indianapolis Indiana USA.
  • Gräber S; German Center for Neurodegenerative Diseases Munich Germany.
  • Lee JH; Department of Neurology Ludwig-Maximilians-Universität München Munich Germany.
  • Chhatwal JP; German Center for Neurodegenerative Diseases Munich Germany.
  • Morris JC; Department of Neurology Ludwig-Maximilians-Universität München Munich Germany.
  • Bateman R; Neuroscience Research Australia Sydney New South Wales Australia.
  • Hassenstab J; School of Medical Sciences University of New South Wales Sydney New South Wales Australia.
Alzheimers Dement (Amst) ; 12(1): e12038, 2020.
Article em En | MEDLINE | ID: mdl-32587883
INTRODUCTION: Changes in personality characteristics are associated with the onset of symptoms in Alzheimer's disease (AD) and may even precede clinical diagnosis. However, personality changes caused by disease progression can be difficult to separate from changes that occur with normal aging. The Dominantly Inherited Alzheimer Network (DIAN) provides a unique cohort in which to relate measures of personality traits to in vivo markers of disease in a much younger sample than in typical late onset AD. METHODS: Personality traits measured with the International Personality Item Pool at baseline from DIAN participants were analyzed as a function of estimated years to onset of clinical symptoms and well-established AD biomarkers. RESULTS: Both neuroticism and conscientiousness were correlated with years to symptom onset and markers of tau pathology in the cerebrospinal fluid. Self-reported conscientiousness and both neuroticism and conscientiousness ratings from a collateral source were correlated with longitudinal rates of cognitive decline such that participants who were rated as higher on neuroticism and lower on conscientiousness exhibited accelerated rates of cognitive decline. DISCUSSION: Personality traits are correlated with the accumulation of AD pathology and time to symptom onset, suggesting that AD progression can influence an individual's personality characteristics. Together these findings suggest that measuring neuroticism and conscientiousness may hold utility in tracking disease progression in AD.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Alzheimers Dement (Amst) Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Alzheimers Dement (Amst) Ano de publicação: 2020 Tipo de documento: Article